loadpatents
name:-0.036193132400513
name:-0.01568603515625
name:-0.0018670558929443
ADAMS; Nicholas D. Patent Filings

ADAMS; Nicholas D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ADAMS; Nicholas D..The latest application filed is for "quinoline derivatives as pi3 kinase inhibitors".

Company Profile
0.15.35
  • ADAMS; Nicholas D. - Collegeville PA
  • Adams; Nicholas D. - Philadelphia PA
  • Adams; Nicholas D. - Royersford PA
  • Adams, Nicholas D. - Royers Ford PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Quinoline Derivatives As Pi3 Kinase Inhibitors
App 20140296224 - ADAMS; Nicholas D. ;   et al.
2014-10-02
Triazolones as fatty acid synthase inhibitors
Grant 8,802,864 - Adams , et al. August 12, 2
2014-08-12
Imidazole-benzamide anti-cancer agents
Grant 8,772,507 - Qian , et al. July 8, 2
2014-07-08
Pyrimidinone Derivatives As Fatty Acid Synthase Inhibitors
App 20130303551 - Adams; Nicholas D. ;   et al.
2013-11-14
Fatty Acid Synthase Inhibitors
App 20130237535 - Adams; Nicholas D. ;   et al.
2013-09-12
Fatty Acid Synthase Inhibitors
App 20130172384 - Adams; Nicholas D. ;   et al.
2013-07-04
Certain Chemical Entities, Compositions And Methods
App 20130096315 - Qian; Xiangping ;   et al.
2013-04-18
Quinoline derivatives as P13 kinase inhibitors
Grant 8,404,837 - Adams , et al. March 26, 2
2013-03-26
Triazolones As Fatty Acid Synthase Inhibitors
App 20120316151 - Adams; Nicholas D. ;   et al.
2012-12-13
Certain Chemical Entities, Compositions, And Methods
App 20120283287 - Qian; Xiangping ;   et al.
2012-11-08
Quinoline Derivatives As Pi3 Kinase Inhibitors
App 20120165321 - Adams; Nicholas D. ;   et al.
2012-06-28
Imidazopyridinyl benzamide mitotic kinesin inhibitors
Grant 8,207,340 - Qian , et al. June 26, 2
2012-06-26
Imidazopyridinyl benzamide mitotic kinesin inhibitors
Grant 8,163,919 - Qian , et al. April 24, 2
2012-04-24
Pyridosulfonamide Derivatives As P13 Kinase Inhibitors
App 20100311736 - Adams; Nicholas D. ;   et al.
2010-12-09
Imidazoyl-benzamide anti-cancer agents
Grant 7,795,448 - Qian , et al. September 14, 2
2010-09-14
Naphthyridine, Derivatives As P13 Kinase Inhibitors
App 20100179143 - Adams; Nicholas D. ;   et al.
2010-07-15
Quinazoline Derivatives As P13 Kinase Inhibitors
App 20100179144 - Adams; Nicholas D. ;   et al.
2010-07-15
Quinoline Derivatives As P13 Kinase Inhibitors
App 20100168100 - Adams; Nicholas D. ;   et al.
2010-07-01
Quinoline Derivatives As P13 Kinase Inhibitors
App 20100152112 - Adams; Nicholas D. ;   et al.
2010-06-17
Certain Chemical Entities, Compositions, and Methods
App 20100069453 - Qian; Xiangping ;   et al.
2010-03-18
Certain Chemical Entities, Compositions, and Methods
App 20090312365 - Qian; Xiangping ;   et al.
2009-12-17
Thiazolidinedione Derivatives As P13 Kinase Inhibitors
App 20090306074 - Darcy; Michael Gerard ;   et al.
2009-12-10
Certain Chemical Entities, Compositions and Methods
App 20090306127 - Qian; Xiangping ;   et al.
2009-12-10
Certain Chemical Entities, Compositions, And Methods
App 20090286841 - QIAN; Xiangping ;   et al.
2009-11-19
Imidazopyridinyl-benzamide anti-cancer agents
Grant 7,618,981 - Qian , et al. November 17, 2
2009-11-17
Imidazoyl-benzamide anti-cancer agents
Grant 7,582,668 - Qian , et al. September 1, 2
2009-09-01
Thiozolidinedione Derivatives As Pi3 Kinase Inhibitors
App 20090215818 - Adams; Nicholas D. ;   et al.
2009-08-27
N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
Grant 7,504,413 - Qian , et al. March 17, 2
2009-03-17
Azaindole inhibitors of aurora kinases
Grant 7,495,102 - Sarpong , et al. February 24, 2
2009-02-24
Compounds, methods and compositions
Grant 7,482,343 - Zhou , et al. January 27, 2
2009-01-27
Quinazoline Derivatives As P13 Kinase Inhibitors
App 20090018131 - ADAMS; Nicholas D. ;   et al.
2009-01-15
Quinoline Derivatives As Pi3 Kinase Inhibitors
App 20080300239 - Adams; Nicholas D. ;   et al.
2008-12-04
Thiazolidinedione Derivatives As Pi3 Kinase Inhibitors
App 20080255115 - Darcy; Michael Gerard ;   et al.
2008-10-16
Certain chemical entities, compositions, and methods
App 20080255182 - Qian; Xiangping ;   et al.
2008-10-16
Compounds, Compositions, and Methods
App 20080176830 - Adams; Nicholas D. ;   et al.
2008-07-24
Azaindole Inhibitors Of Aurora Kinases
App 20080081808 - Sarpong; Martha A. ;   et al.
2008-04-03
Certain chemical entities, compositions, and methods
App 20070197481 - Qian; Xiangping ;   et al.
2007-08-23
Certain chemical entities, compositions, and methods
App 20070149516 - Qian; Xiangping ;   et al.
2007-06-28
Compounds, methods and compositions
App 20070135432 - Zhou; Han-Jie ;   et al.
2007-06-14
Compounds, methods and compositions
Grant 7,166,595 - Zhou , et al. January 23, 2
2007-01-23
Certain chemical entities, compositions, and methods
App 20060247289 - Qian; Xiangping ;   et al.
2006-11-02
Certain chemical entities, compositions, and methods
App 20060094708 - Qian; Xiangping ;   et al.
2006-05-04
Compounds, methods and compositions
App 20040077662 - Zhou, Han-Jie ;   et al.
2004-04-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed